TCL Archive FDA Commissioner Mark McClellan tells NCI audience that science is far from eliminating cancer as a threat. February 6, 2004
TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
TCL Archive Guest Editorial: The Supreme Court Decision on the ACA and What It Can Mean to Oncology June 29, 2012
TCL Archive Schilskly Promoted to Associate Dean At Chicago, Vogelzang To Direct Center March 5, 1999
